You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MIBG-I131

Showing 1 - 25 of 3,498
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroendocrine Tumors Trial in São Paulo (MIBG-I131)

Withdrawn
  • Neuroendocrine Tumors
  • MIBG-I131
  • São Paulo, SP, Brazil
    AC Camargo Cancer Center
May 13, 2022

Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

Available
  • Neuroblastoma
  • Childhood Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
  • 131 I-MIBG
  • Philadelphia, Pennsylvania
    The Children's Hospital of Philadelphia
Jul 11, 2022

Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Dallas (131 I-Metaiodobenzylguanidine, Potassium Iodide, G-csf)

No longer available
  • Relapsed Neuroblastoma
  • Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine
  • +2 more
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Apr 13, 2022

Neuroblastoma Trial in Canada, United States (131I-MIBG, Vincristine, Irinotecan)

Completed
Has Results
  • Neuroblastoma
  • 131I-MIBG
  • +3 more
  • Los Angeles, California
  • +13 more
May 16, 2022

Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)

Recruiting
  • Neuroblastoma
  • 131I-MIBG
  • +4 more
  • Los Angeles, California
  • +11 more
Jan 30, 2023

Relapsed Neuroblastoma, Metastatic Pheochromocytoma Trial in Minneapolis (131 I-Metaiodobenzylguanidine (131I-MIBG), Potassium

Recruiting
  • Relapsed Neuroblastoma
  • Metastatic Pheochromocytoma
  • 131 I-Metaiodobenzylguanidine (131I-MIBG)
  • +3 more
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Jan 20, 2022

Neuroblastoma, Pheochromocytoma Trial in New Hyde Park (131-I-meta-iodobenzylguanidine)

Available
  • Neuroblastoma
  • Pheochromocytoma
  • New Hyde Park, New York
    Cohen Children's Medical Center
Apr 4, 2022

Glioma, Childhood Brainstem, Neuroblastoma Trial in San Francisco, Boston (External beam radiotherapy,

Not yet recruiting
  • Glioma, Childhood Brainstem
  • Neuroblastoma
  • External beam radiotherapy
  • 131I-Metaiodobenzylguanidine (MIBG)
  • San Francisco, California
  • +1 more
Aug 17, 2023

MIBG Avid Tumors Trial in Columbus (MIBG)

Recruiting
  • MIBG Avid Tumors
  • Columbus, Ohio
    Nationwide Children's Hospital
May 20, 2021

Neuroblastoma, Neuroectodermal Tumors, Tumors Trial in United States (131I-MIBG, 131-MIBG + Vorinostat)

Recruiting
  • Neuroblastoma
  • +2 more
  • San Francisco, California
  • +15 more
Jan 7, 2022

Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

Active, not recruiting
Has Results
  • Disseminated Neuroblastoma
  • +5 more
  • Birmingham, Alabama
  • +22 more
Mar 3, 2022

Neuroblastoma Trial in Madison, Southampton, London (Nivolumab, Ch14.18/CHO)

Recruiting
  • Neuroblastoma
  • Madison, Wisconsin
  • +2 more
Mar 28, 2022

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT

Terminated
  • Pheochromocytoma
  • Paraganglioma
  • F-18 FDOPA PET/CT
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 13, 2023

Lewy Body Disease, Dementia, Parkinsonism Trial in Rochester (meta-iodobenzylguanidine (MIBG) (123I), 123I-MIBG scintigraphy)

Enrolling by invitation
  • Lewy Body Disease
  • +4 more
  • meta-iodobenzylguanidine (MIBG) (123I)
  • 123I-MIBG scintigraphy
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 23, 2022

Very High Risk Neuroblastoma Trial in Villejuif, Utrecht (radiation, drug, procedure)

Recruiting
  • Very High Risk Neuroblastoma
  • 131I-mIBG
  • +3 more
  • Villejuif, Val De Marne, France
  • +1 more
May 31, 2021

Parkinson Disease, Dementia With Lewy Bodies, MSA - Multiple System Atrophy Trial in Leuven, Gent ([18F]-MFBG PET CT,

Not yet recruiting
  • Parkinson Disease
  • +3 more
  • [18F]-MFBG PET CT
  • +3 more
  • Leuven, Vlaams-Brabant, Belgium
  • +1 more
Oct 31, 2023

Neuroblastoma Trial in Copenhagen (18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT))

Recruiting
  • Neuroblastoma
  • 18FmFBG imaging on the Large Field of View PET/CT (Total body PET/CT)
  • Copenhagen, Denmark
    Rigshospitalet, Copenhagen University Hospital
Apr 11, 2023

Neuroblastoma Trial in Lund (iodine I 131 metaiodobenzylguanidine, Fludarabine, Thiotepa)

Active, not recruiting
  • Neuroblastoma
  • iodine I 131 metaiodobenzylguanidine
  • +7 more
  • Lund, Sweden
    Lund University Hospital, Department of Pediatric Oncology and B
Feb 17, 2021

Neuroblastoma Trial in San Francisco (124I-Metaiodobenzylguanidine (MIBG) (no-carrier added), 124I-MIBG (carrier added),

Terminated
  • Neuroblastoma
  • 124I-Metaiodobenzylguanidine (MIBG) (no-carrier added)
  • +2 more
  • San Francisco, California
    University of California, San Francisco
May 12, 2021

HER2-positive Breast Cancer Trial in Shanghai (68Ga/131I-SGMIB-5F7)

Not yet recruiting
  • HER2-positive Breast Cancer
  • 68Ga/131I-SGMIB-5F7
  • Shanghai, China
    Huashan Hospital
Aug 1, 2023

Neuroblastoma Trial in Montréal, Sherbrooke (Radiopharmaceutical 68Ga-DOTATATE)

Recruiting
  • Neuroblastoma
  • Radiopharmaceutical 68Ga-DOTATATE
  • Montréal, Quebec, Canada
  • +2 more
Jan 3, 2023

Thyroid Cancer Trial in New York (131 I-iodine (131-I), 124 I-iodine (124-I))

Active, not recruiting
  • Thyroid Cancer
  • 131 I-iodine (131-I), 124 I-iodine (124-I)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Apr 1, 2022

Use of MIBG Scan Images in PVC Ablations

Completed
  • Premature Ventricular Contractions
  • MIBG nuclear scan
  • Baltimore, Maryland
    University of Maryland Medical Center
Jan 25, 2022

Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

Completed
Has Results
  • Kidney Cancer
  • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Edmonton ([131]I-IAZA)

Withdrawn
  • Locally Advanced Solid Tumors
  • Metastatic Solid Tumors
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Jul 7, 2022